Northern Trust Corp Clene Inc. Transaction History

Northern Trust Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.31 - $0.44 $18,829 - $26,725	60,740 Added 35.89%	229,965 $82,000
Q1 2024 May 14, 2024	BUY	$0.28 - $0.53 $1,043 - $1,974	3,726 Added 2.25%	169,225 $72,000
Q4 2023 Feb 13, 2024	BUY	$0.26 - $0.55 $15,324 - $32,416	58,939 Added 55.31%	165,499 $49,000
Q3 2023 Nov 13, 2023	BUY	$0.46 - $0.87 $28,423 - $53,757	61,790 Added 138.02%	106,560 $53,000
Q1 2023 May 15, 2023	BUY	$0.95 - $1.62 $7,218 - $12,308	7,598 Added 20.44%	44,770 $50,000
Q3 2022 Nov 14, 2022	BUY	$0.33 - $73.0 $352 - $77,964	1,068 Added 2.96%	37,172 $104,000
Q2 2022 Aug 12, 2022	SELL	$2.1 - $4.12 $298,666 - $585,954	-142,222 Reduced 79.75%	36,104 $91,000
Q1 2022 May 13, 2022	SELL	$2.42 - $4.42 $19,546 - $35,700	-8,077 Reduced 4.33%	178,326 $703,000
Q4 2021 Feb 08, 2022	BUY	$3.95 - $7.53 $797 - $1,521	202 Added 0.11%	186,403 $764,000
Q3 2021 Nov 15, 2021	BUY	$6.83 - $13.58 $706,433 - $1.4 Million	103,431 Added 124.96%	186,201 $1.27 Million
Q2 2021 Aug 13, 2021	BUY	$6.98 - $13.33 $296,817 - $566,844	42,524 Added 105.66%	82,770 $931,000
Q1 2021 May 12, 2021	BUY	$6.39 - $16.3 $257,171 - $656,009	40,246 New	40,246 $514,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.